My view is that the best 'advertising' A2M can do is via philanthropy and science avenues. For example donating to pediatric hospital and health services and related causes.
A somewhat more radical possibility is that they could sponsor breastfeeding education / services (e.g. lactation consultants etc.). It would send a genuine signal that they are providing a product that is secondary to breastfeeding i.e. when it isn't possible or practical. And it would be on brand with the notion that A2 milk is more similar to human breast milk.
To your point about repercussions and crossing the lines, it is a voluntary and self-enforced code so I don't think there are repercussions other than the reputational damage that could be caused if done inappropriately.
@grimmy77 Agree definitely that the AU market is less material than many make out. However I do think it could be hugely significant for the company if they can get the relationship with hospitals right in any market in which they operate (e.g. including China). The other avenue here is in research partnerships with hospitals - and I think they do have some of these in China.
A2M Price at posting:
$5.78 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)